ClearPoint Neuro (CLPT) Net Margin (2011 - 2026)
ClearPoint Neuro (CLPT) reported Net Margin of 78.76% for Q1 2026, down 774.0% on a YoY basis from 11.69% in Q1 2025, and down 5.75% sequentially from 74.48% in Q4 2025.
ClearPoint Neuro (CLPT) Net Margin (2011 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 15 years of Net Margin data on file, last reported at 78.76% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 774.0% year-over-year to 78.76%; the trailing twelve-month figure through Mar 2026 stood at 71.49% (down 903.0% YoY), and the FY2025 full-year result was 68.99%, down 1085.0% from the prior year.
- Net Margin declined to 78.76% in Q1 2026, from 74.48% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 54.27% in Q1 2024 to a low of 282.37% in Q2 2022.
- A 5-year average of 116.49% and a median of 74.48% in 2025 frame the typical range for Net Margin.
- Across the five-year window, Net Margin jumped 36216 bps in 2022 and tumbled 1675 bps in 2025, its largest moves.
- Tracing CLPT's Net Margin over 5 years: stood at 89.7% in 2022, then increased by 20 bps to 71.88% in 2023, then grew by 15 bps to 60.79% in 2024, then slipped by 23 bps to 74.48% in 2025, then declined by 6 bps to 78.76% in 2026.
- Business Quant data shows CLPT's Net Margin at 78.76% in Q1 2026, 74.48% in Q4 2025, and 66.48% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 16.74% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.01% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | -78.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78.76% |
| Dec 31, 2025 | -74.48% |
| Sep 30, 2025 | -66.48% |
| Jun 30, 2025 | -63.34% |
| Mar 31, 2025 | -71.02% |
| Dec 31, 2024 | -60.79% |
| Sep 30, 2024 | -61.24% |
| Jun 30, 2024 | -56.10% |
| Mar 31, 2024 | -54.27% |
| Dec 31, 2023 | -71.88% |
| Sep 30, 2023 | -117.39% |
| Jun 30, 2023 | -188.71% |
| Mar 31, 2023 | -203.35% |
| Dec 31, 2022 | -89.70% |
| Sep 30, 2022 | -214.65% |
| Jun 30, 2022 | -282.37% |
| Mar 31, 2022 | -225.86% |
| Dec 31, 2021 | -95.38% |
| Sep 30, 2021 | -418.28% |
| Jun 30, 2021 | -536.86% |